Nivolumab,Ipilimumab
BMS
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'immune therap']
expanding the reach of immune therapy in crc - non metastatic setting at #esmo22 
MD, PhD. GI Medical Oncologist @istitutotumori. @myESMO #YOC committee member. European. Beauty seeker. #endowarrior. Tweets are my own.